Funding
Series A · Healthtech

Fesarius Therapeutics raises $20m Series A for wound-healing materials

Jefferson Life Sciences, JJDC, NY Ventures and the American Society of Plastic Surgeons participated in the financing.

Updated Oct 16, 2026By RoundOS Funding desk

Fesarius Therapeutics raised $20 million in Series A financing on June 10. Participants included Jefferson Life Sciences, Johnson & Johnson Innovation–JJDC, NY Ventures and the American Society of Plastic Surgeons. The company develops FDA-cleared hydrogel dermal-regeneration templates for wound healing and reconstructive surgery.

Funding history

Series A · This round$20M

Sources

  1. FesariusTherapeuticsprojectstartups.com
  2. prnewswire.com

Similar rounds

All Healthtech rounds →
Guoke Brain-Computer

Beijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.

UndisclosedSeed · Oct 23, 2026
Star Therapeutics

Biotechnology company discovering and developing antibody therapies for diseases with significant unmet need.

$200MPrivate financing · Oct 23, 2026
Pathos AI

Clinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.

$237MSeries E · Oct 23, 2026
Fairy Devices

Tokyo company developing wearable devices and remote-assistance software for industrial field workers.

UndisclosedJICN equity investment · Oct 23, 2026

Related